Chemoradiation Related Acute Morbidity in Carcinoma Cervix and Correlation with Hematologic Toxicity: A South Indian Prospective Study |
Kumaran, Aswathy
(Department of Obstetrics Gynecology, Kasturba Medical College)
Guruvare, Shyamala (Department of Obstetrics Gynecology, Kasturba Medical College) Sharan, Krishna (Department of Radiation Oncology, Kasturba Medical College) Rai, Lavanya (Department of Obstetrics Gynecology, Kasturba Medical College) Hebbar, Shripad (Department of Obstetrics Gynecology, Kasturba Medical College) |
1 | Amouzegar-Hashemi F, Akbari EH, Kalaghchi B, Esmati E (2013). Concurrent chemoradiation with weekly gemcitabine and cisplatin for locally advanced cervical cancer. Asian Pac J Cancer Prev, 14, 5385-9. 과학기술학회마을 DOI ScienceOn |
2 | Bhavaraju VMK, Reed NS, Habeshaw T (2004). Acute toxicity of concomitant treatment of chemoradiation with single agent cisplatin in patients with carcinoma of the cervix. Thai J Physiol Sci, 17, 90-7. |
3 | Ikushima H, Osaki K, Furutani S, et al (2006). Chemoradiation Therapy for Cervical Cancer: Toxicity of concurrent weekly Cisplatin. J Radiation Med, 24, 115-21. DOI ScienceOn |
4 | Green JA, Kirwan JM, Tierney JF, et al (2001). Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet, 358, 781-6. DOI ScienceOn |
5 | Gunawan R, Nuranna L, Supriana N, Sutrisna B, Nuryanto KH (2012). Acute toxicity and outcomes of radiation alone versus concurrent chemoradiation for locoregional advanced stage cervical cancer Indones. J Obstet Gynecol, 36, 37-42. |
6 | Hu Y, Cai Z, Su X (2012). Concurrent weekly cisplatin versus triweekly cisplatin with radiotherapy in the treatment of cervical cancer: a meta-analysis result. Asian Pac J Cancer Prev, 13, 4301-4. 과학기술학회마을 DOI |
7 | Karnofsky DA, Burchenal JH (1949). The Clinical Evaluation of Chemotherapeutic Agents in Cancer. In: MacLeod CM (Ed), Evaluation of Chemotherapeutic Agents. Columbia Univ Press. Page 196. |
8 | Khalid M, Hussain SI, Kanwal T, Nadeem K (2012). Toxicity profile in cervical cancer patients receiving chemoradiation with concurrent parametrial boost. APMC, 6, 9-12. |
9 | Maduro JH, Pras E, Willemse PH, De Vries EG (2003). Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer. Cancer Treat Rev, 29, 471-88. DOI ScienceOn |
10 | Mahantshetty UM, Shrivastava S, Roy D, et al (2010). Concomitant chemoradiation in advanced stage carcinoma cervix: A phase III randomised trial. (CRACX Study- NCT 00193791). Int J Radiation Oncol, 78, 141. |
11 | National Cancer Institute Common Terminology Criteria for Adverse Events v4.0 (2009). NCI, NIH, DHHS.NIH publication # 09-7473. |
12 | Tan LT, Russell S, Burgess L (2004). Acute toxicity of chemo-radiotherapy for cervical cancer: the Addenbrooke's experience. J Clin Oncol, 16, 255-60. DOI ScienceOn |
13 | Rose P, Bundy B, Watskins E (1999). Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cancer. N Engl J Med, 340, 1144-53. DOI ScienceOn |
14 | Yuenyao P, Chumworathayi B, Luanratanakorn S, et al (2007). Hematologic toxicities of cisplatin concurrent chemoradiation in cervical cancer at Ubonrajchathani Cancer Center. Srinagarind Med J, 22, 127-32. |